NRx Pharmaceuticals Announces Strategic Change in Development of NRX-100 (IV Ketamine) at Dawson James Small Cap Investor Conference

Previously announced data sharing agreement for intravenous ketamine Newly available data highlight the need for a labeled form of IV ketamine that can qualify...

Related Keywords

Israel ,France ,Nrx Pharma ,Company Quarterly Reports On Form ,Nrx Pharmaceuticals ,Alvogen Pharmaceuticals ,Exchange Commission ,Nrxp Nrx Pharmaceuticals ,Prnewswire Nrx Pharmaceuticals Inc ,Nasdaq ,Data Sharing Agreement ,Fast Track Designation ,Breakthrough Therapy Designation ,Special Protocol Agreement ,Biomarker Letter ,Suicidal Treatment Resistant Bipolar Depression ,Acute Suicidal Ideation ,Urinary Tract Infections ,Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,